1 Duran-Salgado MB,Rubio-Guerra AF.Diabetic nephropathy and inflammation[J] .WorldJournal of Diabetes,2014,5(3):393-398. 2 Ronzoni L,Sonzogni L,Duca L,et al.Growth differentiation factor-15 expression and regulation during erythroid-differentiationin non-transfusion dependent thalassemia[J].Blood Cells Molecules & Diseases,2015,54(1):26-28. 3 Sporrer D,Weber M,Wanninger J,et al.Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity[J].Eur J Clin Invest,2009,39(8):671-679. 4 Najafian B,Alpers CE,Fogo AB.Pathology of human diabetic nephropathy[J].Contrib Nephrol,2011,170(4):36-47. 5 Tan RJ,Liu Y.Matrix metalloproteinases in kidney homeostasis and diseases[J].Am J Physiol Renal Physiol,2012,302(11):F1351-F1361. 6 崔小璠,刘蕊.尿白蛋白排泄率的检测现状及临床应用[J].检验医学,2010,25(11):909-913. 7 周健,庞璨,包玉倩,等.糖化血红蛋白诊断糖尿病的关键问题:诊断切点及与糖尿病筛查和预防[J].中华糖尿病杂志,2014,6(12):845-848. 8 韩俊霞,成兴波,熊佩华,等.2型糖尿病巨噬细胞抑制因子-1水平的改变及其临床意义[J].中国糖尿病杂志,2013,21(3):226-228. 9 Bauskin AR,Zhang HP,Fairlie WD,et al.The propeptide of macro-phage inhibitory cytokine(MIC-1),a TGF-beta superfamily member,acts as a quality control determinant for correctly folded MIC-1[J].EMBO J,2000,19(10):2212-2220. 10 李慧,高方,薛耀明,等.2型糖尿病肾病患者生长分化因子-15的表达及临床意义[J].南方医科大学学报,2014,34(3):387-390. 11 胡伟,胡孝彬,陈江,等.2型糖尿病肾病患者血清同型半胱氨酸、脂蛋白(α)和胱抑素 C 测定结果分析[J].海南医学,2014,25(20):3009-3011. 12 Moller H J,Nielsen M J,Maniecki M B,et al.Soluble macrophage-de-rived CD163:a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding[J].Immunobiology,2010,215(5):406-412. 13 Kowal K,Silver R,Slawinska E,et al.CD163 and its role in inflammation[J].Folia Histochemica et Cytobiologica,2011,49(3):365-374. 14 Onfre G,Kolácková M,Jankovicová K,et al.Scavenger receptor CD163 and its biological functions[J].Acta Medica (Hradec Kralove),2009,52(2):57-61. 15 王祥德,郑红波.糖尿病动脉粥样硬化患者血清sCD163和oxLDL检测的临床意义[J].现代实用医学,2013,25(5):520-521. |